Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
基本信息
- 批准号:10339915
- 负责人:
- 金额:$ 78.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Acute myocardial infarction (AMI) is consistently ranked as one of the top five most expensive conditions billed
to Medicare and has been the target of several cost containment measures, including Medicare’s Hospital
Readmissions Reduction Program. To improve outcomes after AMI hospitalizations, payers have implemented
public reporting, financial penalties, and alternative payment models that incentivize the assumption of financial
risk such as capitation. These measures have not been accompanied by evidence-based guidelines on how
health systems can improve outcomes after hospitalization. An impediment to such guidance has been an
incomplete understanding of patient-level factors that may influence the effectiveness of strategies to improve
post-AMI hospitalization outcomes as applied in real-world settings. Notably, 30% of patients hospitalized for
AMI are age ≥ 75. These patients have lower physiologic reserve and more functional impairments, including
those in cognition and physical capabilities, than younger patients. In the SILVER-AMI study, we enrolled 3041
patients age ≥ 75 hospitalized for AMI at 94 hospitals. The primary objective was to evaluate the contribution of
functional impairments and geriatric conditions to improving risk prediction for mortality within 6 months of
hospital discharge. The premise of the SILVER-AMI study was that risk prediction at the time of discharge could
identify high-risk patients who might benefit from more intensive post-hospital care. Findings from SILVER-AMI
have demonstrated that functional impairments substantially improve risk prediction for important outcomes. We
did not obtain Medicare data in this study so could not examine strategies being deployed in an effort to improve
post-AMI outcomes. The overall objective of this proposal is to refine our understanding of the impacts of
home health care (HHC) (Aim 1), early outpatient care (Aim 2), and Medicare Advantage (MA) (Aim 3) after AMI
hospitalization by examining their effects in the context of functional impairments and illness severity. We will
focus on outcomes of primary importance to older patients, including “home days” (days alive out of the hospital
and other inpatient facilities) and health status, as well as disease-specific outcomes of relevance post-AMI. We
will merge data from the SILVER-AMI study with Medicare data to achieve our aims. Combining these data
sources will afford us the unique opportunity of accounting for an array of rigorously assessed covariates that
are not generally available in studies using only administrative data and to identify patients who may benefit most
from post-discharge services. In addition to accounting for a rich array of measured confounders, we will employ
advanced statistical techniques to address bias from unmeasured confounding. We have assembled a team with
a track record of collaboration and expertise in cardiovascular outcomes, home health care, outpatient care
delivery, epidemiology, and biostatistics. This hypothesis-driven research will leverage the most comprehensive
set of data on functional impairments and geriatric conditions collected during AMI hospitalization on a large,
national cohort to inform strategies to improve outcomes of importance to older patients.
急性心肌梗塞(AMI)始终被评为最昂贵的五个最昂贵条件之一
对Medicare,一直是Medicare医院在内的几项费用遏制措施的目标
减少再入学计划。为了改善AMI住院后的结果,付款人已实施
公开报告,经济罚款和替代付款模式,这些模式激励财务假设
诸如大写之类的风险。这些措施尚未通过基于证据的指南积累
卫生系统可以在住院后改善预后。对这种指导的障碍是
对可能影响策略改善策略有效性的患者级因素的不完全理解
现实环境中应用的AMI后住院结果。值得注意的是,有30%的患者住院
AMI年龄≥75岁。这些患者的生理储备较低和功能障碍,包括
与年轻患者相比,认知和身体能力的人。在银色AMI研究中,我们注册了3041
≥75岁的患者在94家医院住院。主要目的是评估
功能障碍和老年状况,以在6个月内6个月内改善死亡率的风险预测
医院出院。白银研究的前提是,出院时的风险预测可能
确定可能受益于院后护理的高危患者。 Silver-Ami的发现
已经证明,功能障碍大大改善了重要结果的风险预测。我们
在这项研究中没有获得医疗保险数据,因此无法检查正在部署的策略以改进
后的结果。该提案的总体目的是完善我们对
家庭医疗保健(HHC)(AIM 1),早期门诊护理(AIM 2)和Medicare Advantage(MA)(AIM 3)AMI之后
通过在功能障碍和疾病严重程度的背景下检查其影响来住院。我们将
专注于对老年患者的主要重要性,包括“家庭日”(还活在医院之外
以及其他住院设施)和健康状况,以及AMI后相关性的特定疾病结果。我们
将将银色AMI研究中的数据与Medicare数据合并,以实现我们的目标。结合这些数据
资料来源将为我们提供一系列严格评估的协变量的独特机会,这些机会
通常在研究中仅使用行政数据并确定可能受益大多数的患者
来自后收费服务。除了考虑丰富的测量混杂因素外,我们还将雇用
先进的统计技术,以解决无法衡量的混杂因素的偏见。我们已经组建了一个团队
心血管成果,家庭保健,门诊护理方面的协作和专业知识的记录
分娩,流行病学和生物统计学。这项假设驱动的研究将利用最全面的
关于在AMI住院期间收集的功能障碍和老年病情的数据集
国家队列为提高对老年患者重要性的策略提供了信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Sarwat I Chaudhry的其他基金
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
- 批准号:1057634910576349
- 财政年份:2022
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
NIA Short Term Research Training: Students in Health Professional Schools
NIA 短期研究培训:卫生专业学校的学生
- 批准号:1061660710616607
- 财政年份:2016
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
NIA Short Term Research Training: Students in Health Professional Schools
NIA 短期研究培训:卫生专业学校的学生
- 批准号:1041094310410943
- 财政年份:2016
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Yale Center for Healthcare Innovation, Redesign and Learning (CHIRAL)
耶鲁医疗保健创新、重新设计和学习中心 (CHIRAL)
- 批准号:88043168804316
- 财政年份:2014
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Yale Center for Healthcare Innovation, Redesign and Learning (CHIRAL)
耶鲁医疗保健创新、重新设计和学习中心 (CHIRAL)
- 批准号:93522939352293
- 财政年份:2014
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Risk Stratification in Older Persons with Acute Myocardial Infarction: SILVER-AMI
老年人急性心肌梗塞的风险分层:SILVER-AMI
- 批准号:88931318893131
- 财政年份:2012
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Risk Stratification in Older Persons with Acute Myocardial Infarction: SILVER-AMI
老年人急性心肌梗塞的风险分层:SILVER-AMI
- 批准号:90597689059768
- 财政年份:2012
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Risk Stratification in Older Persons with Acute Myocardial Infarction: SILVER-AMI
老年人急性心肌梗塞的风险分层:SILVER-AMI
- 批准号:83434878343487
- 财政年份:2012
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Risk Stratification in Older Persons with Acute Myocardial Infarction: SILVER-AMI
老年人急性心肌梗塞的风险分层:SILVER-AMI
- 批准号:85329808532980
- 财政年份:2012
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Risk Stratification in Older Persons with Acute Myocardial Infarction: SILVER-AMI
老年人急性心肌梗塞的风险分层:SILVER-AMI
- 批准号:86759378675937
- 财政年份:2012
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
相似国自然基金
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长链非编码RNA MIPRL在急性心肌梗塞中的作用及分子机制
- 批准号:81870275
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Cdx2+胎盘干细胞移植治疗急性心肌梗塞的实验研究
- 批准号:81270281
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
LPA在急性心梗诱发心律失常中的作用及其电生理机制
- 批准号:81170163
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
心肌缺氧/再灌注与细胞移植多功能集成微流控芯片模型构建及应用
- 批准号:21175107
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:1074944810749448
- 财政年份:2023
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Leveraging a novel health records platform to predict the development of cardiovascular disease following kidney transplantation
利用新型健康记录平台预测肾移植后心血管疾病的发展
- 批准号:1067932210679322
- 财政年份:2023
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality
查明美国全国心血管疾病死亡率停滞不前的原因
- 批准号:1058580010585800
- 财政年份:2023
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
- 批准号:1057634910576349
- 财政年份:2022
- 资助金额:$ 78.54万$ 78.54万
- 项目类别:
Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis Patients
心血管疾病的性别差异和透析患者的最佳冠状动脉血运重建
- 批准号:1040238810402388
- 财政年份:2021
- 资助金额:$ 78.54万$ 78.54万
- 项目类别: